Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications

<p>Block I Tools, Toolstations and Models<br>1. Germ-Free Animals as a Tool to Study Indigenous Microbiota<br>2. Germ-Free Mouse Technology in Cardiovascular Research<br>3. The Gut Microbiome Beyond the BacteriomedThe Neglected Role of Virome and Mycobiome in Health and Disease<br>4. Techniques for Phenotyping the Gut Microbiota Metabolome<br>5. Metabolomics Tools and Information Retrieval in Microbiome Hacking<br>6. Laboratory Simulators of the Colon Microbiome<br>7. Potential of Metabolomics to Breath Tests</p> <p>Block II Background Information<br>8. Metabolome and Microbiome From Infancy to Elderly<br>9. The Oral Microbiome<br>10. The Gastric Microbiome in Benign and Malignant Diseases<br>11. The Human Vaginal Microbiome<br>12. Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine<br>13. Role of the Microbiome in Intestinal Barrier Function and Immune Defense<br>14. The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric Surgery</p> <p>Block III Established and Experimental Interventions<br>15. Use of Probiotics in Inflammatory Bowel Disease<br>16. Current Status of Fecal Microbiota Transplantation<br>17. Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials<br>18. Current Options for Fecal Transplantation in Clostridium difficile Infection<br>19. Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy<br>20. The Unknown Effect of AntibioticInduced Dysbiosis on the Gut Microbiota<br>21. The Myth and Therapeutic Potentials of Postbiotics</p> <p>Block IV Diagnostic and Therapeutical Applications<br>22. The Microbiome and Metabolome in Metabolic Syndrome<br>23. The Gut Microbiota as a Therapeutic Approach for Obesity<br>24. The Gut Microbiome After Bariatric Surgery<br>25. Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management<br>26. The Emerging Role of MicrobiomeeGuteBrain Axis in Functional Gastrointestinal Disorders<br>27. The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease<br>28. The Microbiome and Metabolome in Alcoholic Liver Disease<br>29. The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis<br>30. Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis?<br>31. The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease</p>